<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">15312</article-id><article-id pub-id-type="doi">10.7554/eLife.15312</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology and Stem Cells</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Detection and manipulation of live antigen-expressing cells using conditionally stable nanobodies</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-51234"><name><surname>Tang</surname><given-names>Jonathan CY</given-names></name><aff><institution content-type="dept">Departments of Genetics and Ophthalmology</institution>, <institution>Howard Hughes Medical Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-52162"><name><surname>Drokhlyansky</surname><given-names>Eugene</given-names></name><aff><institution content-type="dept">Departments of Genetics and Ophthalmology</institution>, <institution>Howard Hughes Medical Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-52163"><name><surname>Etemad</surname><given-names>Behzad</given-names></name><aff><institution content-type="dept">Brigham and Women's Hospital</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52164"><name><surname>Rudolph</surname><given-names>Stephanie</given-names></name><aff><institution content-type="dept">Department of Neurobiology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52165"><name><surname>Guo</surname><given-names>Binggege</given-names></name><aff><institution content-type="dept">Departments of Genetics and Ophthalmology</institution>, <institution>Howard Hughes Medical Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52166"><name><surname>Wang</surname><given-names>Sui</given-names></name><aff><institution content-type="dept">Departments of Genetics and Ophthalmology</institution>, <institution>Howard Hughes Medical Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-52167"><name><surname>Ellis</surname><given-names>Emily G</given-names></name><aff><institution content-type="dept">Department of Neurobiology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52168"><name><surname>Li</surname><given-names>Jonathan Z</given-names></name><aff><institution content-type="dept">Brigham and Women's Hospital</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-2493"><name><surname>Cepko</surname><given-names>Constance L</given-names></name><aff><institution content-type="dept">Departments of Genetics and Ophthalmology</institution>, <institution>Howard Hughes Medical Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country><email>cepko@genetics.med.harvard.edu</email></aff><xref ref-type="fn" rid="conf5"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1132"><name><surname>Luo</surname><given-names>Liqun</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Stanford University</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>05</month><year>2016</year></pub-date><elocation-id>e15312</elocation-id><supplementary-material><ext-link xlink:href="elife-15312-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>17</day><month>02</month><year>2016</year></date><date date-type="accepted"><day>19</day><month>05</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, Tang et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Tang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>The ability to detect and/or manipulate specific cell populations based upon the presence of intracellular protein epitopes would enable many types of studies and applications. Protein binders such as nanobodies (Nbs) can target untagged proteins (antigens) in the intracellular environment. However, genetically expressed protein binders are stable regardless of antigen expression, complicating their use for applications that require cell-specificity. Here, we created a conditional system in which the stability of an Nb depends upon an antigen of interest. We identified Nb framework mutations that can be used to rapidly create destabilized Nbs. Fusion of destabilized Nbs to various proteins enabled applications in living cells, such as optogenetic control of neural activity in specific cell types in the mouse brain, and detection of HIV-infected human cells by flow cytometry. These approaches are generalizable to other protein binders, and enable the rapid generation of single-polypeptide sensors and effectors active in cells expressing specific intracellular proteins.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Jonathan CY Tang, Submitted a patent application regarding destabilized nanobodies. International Application No. PCT/US2016/027749 Priority: US Prov. Appl. No. 62/148,595.</p></fn><fn fn-type="conflict" id="conf3"><p>Eugene Drokhlyansky, Submitted a patent application regarding destabilized nanobodies. International Application No. PCT/US2016/027749Priority: US Prov. Appl. No. 62/148,595.</p></fn><fn fn-type="conflict" id="conf4"><p>Sui Wang, Submitted a patent application regarding destabilized nanobodies. International Application No. PCT/US2016/027749Priority: US Prov. Appl. No. 62/148,595.</p></fn><fn fn-type="conflict" id="conf5"><p>Constance L Cepko, Submitted a patent application regarding destabilized nanobodies. International Application No. PCT/US2016/027749 Priority: US Prov. Appl. No. 62/148,595.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The Institutional Animal Care and Use Committee at Harvard Medical School approved all animal experiments conducted under protocols 428-R98, 04537 and 1493.</p></fn></fn-group></back></article>